![An illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes with the logo of pharmaceutical company AstraZeneca on Nov. 17, 2020. [Photo via Getty Images]](https://i0.wp.com/www.sudanspost.com/wp-content/uploads/2021/02/ON-EC763_Vaccin_GR_20201123055418.jpg?resize=1024%2C668&ssl=1)
Dr. John Rumunu, director-general for preventive health services at the ministry of health told reporters during routine COVID-19 weekly media briefly in Juba on Sunday that COVAX has allocated COVID-19 does to the world’s youngest nation to protect its citizens against the deadly pandemic.
“I am happy to inform you that we have met all the requirement, and we have received information from COVAX that there is 864,000 does of AstraZeneca a vaccine that has been allocated to South Sudan and depending on the process, South Sudan will be able to receive this consignment latest end of February,” Rumunu told reporters
The Ministry of Health applied to Global Alliance for Vaccines to acquired coronavirus vaccines to protect citizens from the pandemic in January.
The health official said they will target health workers, and people with underlying conditions.
“Who should be prioritized for the vaccine, we have forth line health workers, we have people having underlying conditions like diabetes, we have categories of people living with HIV/AIDS and economically active population, ” Rumunu said.
As of Sunday, 7 February 2021, there have been 4,492 confirmed cases of COVID-19 with 66 deaths.